A detailed history of Dunhill Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Dunhill Financial, LLC holds 469 shares of NVO stock, worth $47,716. This represents 0.03% of its overall portfolio holdings.

Number of Shares
469
Previous 158 196.84%
Holding current value
$47,716
Previous $22.6 Million 147.51%
% of portfolio
0.03%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$119.07 - $145.42 $37,030 - $45,225
311 Added 196.84%
469 $55.8 Million
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $2,042 - $2,718
20 Added 14.49%
158 $20.3 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $12,113 - $14,552
138 New
138 $12.9 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.